FDA advisers vote in favor of Biogen and Eisai’s collaborative Alzheimer’s treatment
June 09, 2023 at 17:12 PM EDT
If granted full FDA approval, which could come in early July, treatment could boost annual Medicare spending by nearly $9 billion, analysis shows.
